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Enterohaemorrhagic Escherichia coli (EHEC) and enteropathogenic E. coli (EPEC) translocate
dozens of type III secretion system effectors, including the WxxxE effectors Map, EspM and EspT
that activate Rho GTPases. While map, which is carried on the LEE pathogenicity island, is
absolutely conserved among EPEC and EHEC strains, the prevalence of espM and espT is not
known. Here we report the results of a large screen aimed at determining the prevalence of espM
and espT among clinical EPEC and EHEC isolates. The results suggest that espM, detected in
51% of the tested strains, is more commonly found in EPEC and EHEC serogroups that are
linked to severe human infections. In contrast, espT was absent from all the EHEC isolates and
was found in only 1.8% of the tested EPEC strains. Further characterization of the virulence gene
repertoire of the espT-positive strains led to the identification of a new f2 intimin variant. All the
espT-positive strains but two contained the tccP gene. espT was first found in Citrobacter
rodentium and later in silico in EPEC E110019, which is of particular interest as this strain was
responsible for a particularly severe diarrhoeal outbreak in Finland in 1987 that affected 650
individuals in a school complex and an additional 137 associated household members. Comparing
the protein sequences of EspT to that of E110019 showed a high level of conservation, with only
three strains encoding EspT that differed in 6 amino acids. At present, it is not clear why espT is so
rare, and what impact EspM and EspT have on EPEC and EHEC infection.
INTRODUCTION
Enterohaemorrhagic Escherichia coli (EHEC) comprise a
subgroup of Shiga-toxin producing E. coli that can cause
bloody diarrhoea, haemorrhagic colitis and haemolytic-
uraemic syndrome (reviewed by Tarr, 1995). EHEC
O157:H7 is the most common and virulent serotype that
is implicated worldwide in human disease, although non-
O157 EHEC serotypes, particularly O26, O103, O111,
O118 and O145, are also prevalent (reviewed by Nataro &
Kaper, 1998). Enteropathogenic E. coli (EPEC) is the
leading cause of mortality due to infantile diarrhoea in the
developing world (reviewed by Chen & Frankel, 2005).
EPEC strains comprise a diverse group of serotypes that
may be divided into typical EPEC (tEPEC) and atypical
EPEC (aEPEC) based on the presence or absence of a large
virulence plasmid (EAF), respectively (Kaper, 1996)
EPEC and EHEC, as well as the mouse pathogen
Citrobacter rodentium (reviewed by Mundy et al., 2005),
colonize the gut mucosa via attaching and effacing (A/E)
Abbreviations: A/E, attaching and effacing; aEPEC, atypical
enteropathogenic Escherichia coli; EHEC, enterohaemorrhagic
Escherichia coli; EPEC, enteropathogenic Escherichia coli; SF, sorbitol
fermenting; tEPEC, typical enteropathogenic Escherichia coli.
3These authors contributed equally to this work.
The GenBank/EMBL/DDBJ accession numbers for the eae-f2 variant
gene sequences of E110019 and T2381-8 are FM872419 and
FM872420, respectively.
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the bacteria with the enterocyte plasma membrane and
localized breakdown of the brush border microvilli
(Knutton et al., 1987; reviewed by Frankel & Phillips,
2008). The ability to induce A/E lesions is associated with
the LEE pathogenicity island, which encodes gene regula-
tors, intimin (Jerse et al., 1990), a type III secretion system
(Jarvis et al., 1995), chaperones, translocator and effector
proteins (reviewed by Garmendia et al., 2005a). The
principal effector protein needed for A/E lesion formation
is Tir, which, once translocated, is integrated into the
mammalian cell plasma membrane where it serves as a
receptor for intimin (Kenny et al., 1997). Recent studies
have shown that different EPEC and EHEC strains encode
distinct intimin and Tir types; currently there have been 27
intimin and 8 Tir types reported (Blanco et al., 2006a, b;
Garrido et al., 2006; J. Blanco, unpublished data).
EPEC E2348/69, which is the prototype strain used
worldwide to study EPEC infection, encodes 21 LEE and
non-LEE effectors (Iguchi et al., 2009). Other EPEC strains
encode a greater number of T3SS effectors: 28 in EPEC
B171 (Ogura et al., 2008), 40 in EPEC E22 and 24 in EPEC
E110019 (Iguchi et al., 2009). EHEC O157 Sakai encodes
50 effectors, representing the most complex repertoire
among A/E pathogens (Tobe et al., 2006). This shows that
the A/E pathogen class is much more heterogeneous than
was previously thought, comprising strains expressing
unique complements of T3SS effector proteins and as a
result employing diverse infection strategies.
A novel family of T3SS effectors, known as the WxxxE
proteins, was recently described (Alto et al., 2006), which
include IpgB1 and IpgB2 from Shigella, SifA and SifB from
Salmonella, and Map (Kenny & Jepson, 2000), EspM
(Arbeloa et al., 2008) and EspT (Bulgin et al., 2008) from
EPEC and EHEC. Members of the WxxxE family are
important virulence factors. For example, SifA is essential
for intracellular Salmonella survival (Beuzon et al., 2000)
and IpgB1 is essential for Shigella cell invasion (Ohya et al.,
2005). Map, which is encoded on the LEE pathogenicity
island and is absolutely conserved among EPEC and EHEC
strains, plays a role in colonization in vivo (Mundy et al.,
2004) and triggers transient filopodia by activating the Rho
GTPase Cdc42 (Kenny et al., 2002; Berger et al., 2009). The
different EspM variants induce formation of stress fibres by
activating RhoA (Arbeloa et al., 2008), while EspT from the
C. rodentium induces formation of extensive lamellipodia
by activation of Rac-1 and Cdc42 (Bulgin et al., 2009). By
sequence homology searches we recently identified homo-
logues of espM and espT in EPEC strain E110019 (Bulgin
et al., 2009), a clinical isolate from a diarrhoeal outbreak in
Table 1. Distribution of espM and espT among 151 non-O157 clinical EHEC strains (Spain)
The strains were isolated in Spain, except for strain FV10110 O111:H8, which was isolated in Germany. espM–espT negative
strains were: ONT:HNT (2), ONT:H5 (1), ONT:H8 (1), ONT:H18 (1), ONT:H39 (1), O2:H27 (1), O8:H2 (1), O8:H19
(1), O15:H16 (1), O15:H28 (1), O18:ND (2), O22:H42 (1), O55:H- (1), O63:HND (2), O64:H21 (1), O76:ND (2),
O76:H19 (2), O84:HNT (1), O84:HND (1), O91:H- (2), O98:H- (1), O104:HNT (4), O113:HND (2), O113:H21 (2),
O117:HND (1), O136:HND (1), O141:HND (1), O146:H- (1), O146:H21 (4), O148:HND (2), O148:H8 (1), O165:H-
(1), O166:HND (1), O166:H28 (1), O168:H8 (1), O174:H21 (1), O183:H- (1).
Serotype (no. of strains) VT type espM espT
OH
ONT (14) HND (7), H- (6), H11 (1) 1, 2 4 0
O5 HND (3) 1, 2 2 0
O14 H- (1) 1 1 0
O26 (37) HND (17), H- (2), H8 (1), H11 (17) 1 36 0
O32 H6 (1) 1 1 0
O69 H21 (1) 1 1 0
O80 HND (1) 1, 2 1 0
O98 H21 (1) 1 1 0
O103 (6) HND (1), H2 (5) 1, 2 6 0
O111 (10) HND (5), H- (3), H8 (1)*, H10 (1) 1, 2 9 0
O118 (6) HND (3), H- (1), H16 (2) 1 6 0
O121 (2) H19 (1), H40 (1) 2 2 0
O145 (3) HND (1), H- (2) 1, 2 3 0
O146 HND (10) 1, 2 1 0
O156 H25 (2) 1 2 0
O139, O141 HND (1) 1, 2 1 0
VT, Verocytotoxin.
*Strain FV10110 O111:H8 was isolated in Germany.
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100% identical to the EspM of EHEC O157 Sakai, while
EspTE110019 shares 79% sequence homology with the C.
rodentium EspT, including the WxxxE motif. The aim of
this study was to determine the prevalence of espM and
espT among clinical EPEC and EHEC isolates.
METHODS
Bacterial strains. The bacterial strains used in this study included
EPEC strains E2348/69 (Levine et al., 1978) and E110019 (Viljanen et
al., 1990), EHEC O157:H7 strain Sakai (Hayashi et al., 2001), C.
rodentium strain ICC169 (Barthold et al., 1976; Wiles et al., 2004),
and 932 clinical EHEC and EPEC isolates.
Serotyping. The determination of O and H antigens was carried out
using the method described by Guine ´e et al. (1981) employing all
available O (O1–O185) and H (H1–H56) antisera. All antisera were
obtained and absorbed with the corresponding cross-reacting
antigens to remove the non-specific agglutinins. The O antisera were
produced in the Laboratorio de Referencia de E. coli and the H
antisera were obtained from the Statens Serum Institut, Copenhagen,
Denmark.
Prevalence of espT and espM among clinical EPEC and EHEC
strains. In order to screen for espM by PCR we used the eight espM
sequences identified in EHEC O157 strain Sakai, EPEC strains B171
and E22, and C. rodentium to design common internal espM-1 (59-
TCTTTCAGCTCTTTTGGTAT-39) and espM-2 (59-CCAAAAGAA-
GCATTCCCCATTAT-39) forward and reverse primers (30 cycles of
94 uC for 45 s, 48 uC for 1 min and 72 uC for 1 min). The identity of
representative PCR amplicons was confirmed by DNA sequencing. A
second round of PCR was employed to screen representative espM-1
and espM-2 PCR negative strains using primers espM-3 (59-
TGATGAGGTCATGAAATGTTCAAT-39) and espM-4 (59-ATGATT-
AATAGAACTTTG-39) (30 cycles of 94 uC for 45 s, 50 uC for 1 min
and 72 uC for 1 min).
We used the espT sequences from C. rodentium and E110019 to design
internal espT-1 (59-AATCTCATTCTCTTATC-39)a n de s p T - 2( 5 9-
TCATGTGATGAGTGGATG-39) primers for PCR (30 cycles of 94 uCf o r
45 s, 55 uCf o r1m i na n d7 2uCf o r1m i n ) .
A further three rounds of PCR were employed to screen representative
espT-1 and espT-2 PCR-negative strains using additional common
internal primers espT-3 (59-ATAGATGGTTTCTTTTTAGG-39) and
espT-4 (59-CATCCAACGAGAAACCGCAAT-39), and primers espT-5
(59-CCGgaattcATGCCGGGAACAATAAGCTCCAG-39) and espT-6
(59-GGGAAGCTTTTAGGTTCTCTGAGCCTC-39) and espT-7 (59-
TTGAATTCATGCATAGCATGCCAGGA-39) and espT-8 (59-CCAA-
TGCACTGCAGGGAGCATTAAACATATTTTAAATTTCTC-39), which
correspond to the 59 and 39 ends of the C. rodentium and E110019 espT
homologue, respectively (30 cycles of 94 uC for 45 s, 52 uC for 1 min
and 72 uCf o r1m i n ) .
EHEC O157:H7 Sakai, C. rodentium and EPEC E2348/69 were used
as positive and negative controls.
Intimin, Tir and TccP typing of the espT-positive strains. Intimin
and Tir typing was performed by PCR and sequencing as previously
described (Blanco et al., 2006b; Garrido et al., 2006). The nucleotide
sequence of the amplification products purified using a QIAquick
DNA purification kit (Qiagen) was determined by the dideoxynu-
cleotide triphosphate chain-termination method of Sanger, with a
BigDye terminator v3.1 cycle sequencing kit and an ABI 3100 genetic
analyzer (Applied Biosystems). The new eae sequences of the strains
analysed were deposited in the European Bioinformatics Institute
EMBL nucleotide sequence database. The presence of tccP2 was
determined by PCR as described by Whale et al. (2007).
Table 2. Distribution of espM and espT among 132 tEPEC strains
espM–espT negative strains were: ONT:HND (1), ONT:H1, H12 (1), ONT:H8 (1), ONT:H25 (1), O1:H1, H12 (1),
O55:H8 (1), O86:H8 (1), O88:H5 (2), O98:HND (1), O127:H40 (3), O131:H46 (2), O153:H8 (1), O157:H45 (1).
Serotype (no. of strains) Origin espM espT
OH
ONT (2) H6 (1), H10 (1) Bolivia 2 0
O23 (2) HND (1), H8 (1) Spain 2 0
O49 H10 (5) Spain, Bolivia 5 0
O55 (22) H- (8), H6 (6), H51 (8) Uruguay, Bolivia, Brazil, UK 19 0
O86 (6) H- (2), H34 (4) Bolivia, Brazil 6 0
O88 (17) H- (1), H6 (1), H25 (15) Spain, Bolivia 3 0
O103 (3) H- (1), H7 (2) Bolivia 3 0
O109 H- (2) Spain, Chile 1 0
O111 (20) H- (12), H2 (7), H25 (1) Spain, Bolivia, Brazil, Uruguay 19 1
O118 (4) HND (1), H- (1), H5 (2) Spain, Germany 4 0
O119 (17) H- (2), H6 (15) Bolivia, Brazil, Uruguay 16 0
O125 H- (1) Burundi 1 0
O127 H6 (3) Bolivia, Brazil 1 0
O132 H8 (1) Bolivia 1 0
O142 (6) H6 (2), H34 (4) Brazil, Spain 4 0
O145 H45 (3) Brazil 3 0
O153 H11 (1) Spain 1 0
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espM–espT negative strains were: ONT:H2 (2), ONT:H6 (4), ONT:H9 (1), ONT:H10 (2), ONT:H11, 21, 34 (1), ONT:H19 (2), ONT:H21, 39
(1), ONT:H34 (1), ONT:H40, 43 (2), ONT:H51 (1), O1:H2 (1), O1:H11 (1), O1:H46 (1), O1:H49 (1), O2ab:H45 (1), O2:NT (1), O2:H6
(1), O2:H16 (1), O2:H45 (1), O2:H49 (2), O3:H4 (1), O5:H6 (1), O5:H40 (1), O5:H49 (1), O6:H4 (1), O6:H16 (1), O9:HND (2),
O11:H16 (2), O12:HND (1), O13:H11 (1), O15:H- (2), O15:H7 (1), O16:H- (1), O18:H7 (1), O18:H16 (1), O20:H6 (1), O21:HND (2),
O21:H15 (1), O23:HND (1), O24:H2 (1), O25:HND (2), O25:H1 (1), O26:H2 (1), O28:HND (1), O33:HNT (1), O33:H6 (1), O33:H34 (1),
O34:H- (1), O41:H- (1), O49:H40 (1), O51:H41 (1), O55:H40 (1), O56:H6 (1), O63:HND (1), O64:H40 (1), O71:H1, H12 (2), O76:H19
(1), O84:HND (1), O84:H- (2), O85:H8 (1), O85:H49 (1), O86:HNT (1), O86:HND (1), O88, O168:HND (1), O98:H- (1), O98:H8 (1),
O101:H33 (2), O103:H- (3), O103:H4 (1), O103:H19 (1), O103:H40 (1), O104:H- (2), O105:HND (1), O105:H4 (2), O108:HND (3),
O110:HND (5), O111:H9 (1), O111:H38 (1), O112:H15 (1), O113:HND (4), O113:H- (1), O114:HND (1), O117:H11 (1), O117:H40 (2),
O121:HND (1), O123:HND (1), O123:H19 (1), O123:H45 (1), O125:H6 (3), O127:HND (1), O127:H6 (1), O128:H40 (1), O129:HND (1),
O129:H- (1), O132:HND (3), O132:H5 (3), O137:HND (3), O137:H6 (2), O139:HND (4), O139:H2 (1), O141:HND (10), O145:H2 (1),
O146:H28 (1), O148:H8 (1), O153:H11 (1), O153:H31 (1), O153:H40 (1), O156:H4 (1), O156:H8 (3), O156:H33 (1), O157:H16 (2),
O159:HND (1), O164:H- (1), O167:H27 (1), O168:H- (1), O171:H19 (1), O173:H- (1), O178:H6 (1), O180:HND (1), O180:H2 (1), R:H28
(1).
Serotype (no. of strains) Origin espM espT
OH
ONT (92) HND (38), HNT (4), H- (24), H4 (3), H7 (4), H8 (3), H11 (4), H23 (1),
H33 (2), H40 (6), H45 (3)
Spain, Brazil, Bolivia,
Chile
O1 (3) H7 (1), H40 (1), H45 (1) Brazil, Spain 3 0
O2 (11) ND (3), H40 (8) Spain 3 2
O4 (4) ND (2), H- (1), H1 (1) Spain, Brazil 3 0
O5 ND (7) Spain 2 0
O6 (2) ND (1), H19 (1) Spain 2 0
O8 (5) HND (3), H11 (1), H19 (1) Spain 3 0
O10 (5) HN (3), H- (2) Spain 4 0
O11 HND (4) Spain 4 0
O14 H5 (1) Brazil 1 0
O15 (17) HND (9), H2 (8) Spain 12 0
O18 HND (2) Spain 2 0
O20 HND (2) Spain 2 0
O22 HND (2) Spain 2 0
O25 H2 (1) Spain 1 0
O26 (30) ND (20), H- (6), H11 (4) Spain, Brazil 23 0
O28 H28 (1) Bolivia 1 0
O33 HND (3) Spain 1 0
O49 (12) HND (6), H- (3), H2 (1), H10 (2) Spain, Brazil 6 1
O51 (16) HND (5), H- (2), H1 (1), H40 (6), H49 (2) Spain, Brazil 7 0
O52 H10 (1) Spain 1 0
O57 H7 (3) Spain 3 0
O55 (16) HND (4), H- (1), H6 (1), H7 (9), H51 (1) Spain, Brazil, Bolivia 15 0
O56 H- (1) Spain 1 0
O63 (6) H6 (5), H33 (1) Spain, Brazil 2 0
O64 H25 (2) Spain 1 0
O70 H2 (1) Brazil 1 0
O76 HND (3) Spain 2 0
O80 (9) ND (5), H2 (4) Spain 4 0
O82 (2) HND (1), H10 (1) Spain 2 0
O85 (13) HND (5), H- (2), H31 (5), H43 (1) Spain 4 1
O101 (7) HND (2), H- (5) Spain, Brazil 7 0
O103 (12) HND (11), H2 (1) Spain 4 0
O104 (4) HND (1), H2 (2), H12 (1) Spain, Brazil 2 2
O109 H9 (1) Brazil 1 1
O111 (2) HND (1), H- (1) Spain 2 0
O113 H6 (4) Spain 1 0
O115 (4) HND (1), H8 (3) Spain 3 0
O117 HND (4) Spain 2 0
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Screening O157 and non-O157 EHEC strains for
the presence of espM and espT
We determined the prevalence of espM and espT among 45
non-sorbitol fermenting (non-SF) EHEC O157:H7
(expressing VT1 and VT2), isolated in Spain, Canada and
Bolivia, and two SF EHEC O157:H- (expressing VT2),
isolated in Germany. espM was found in 43 of the non-SF
O157 isolates (96%) and in the 2 SF isolates. We then
screened 151 non-O157 EHEC strains. espM was found in
60 of the 62 (97%) non-O157 EHEC strains belonging to
Table 3. cont.
Serotype (no. of strains) Origin espM espT
OH
O119 HND (2) Spain 2 0
O120 HND (2) Spain 1 0
O123 H- (2) Brazil 2 2
O125 H28 (1) Spain 1 0
O127 H40 (5) Spain, Bolivia 1 0
O128 (4) HND (1), H- (1), H2 (1), H27 (1) Spain 4 0
O132 H34 (3) Spain 3 0
O139 H19 (1) Spain 1 0
O145 (33) Spain, Germany 25 0
O146 HND (1) Spain 1 0
O153 HND (15) Spain 2 0
O154 H9 (1) Brazil 1 1
O156 (8) HND (6), H- (2) Spain 4 0
O157 (5) ND (2), H7 (3) Spain 4 0
O162 (4) H- (2), H21 (1), H33 (1) Spain, Brazil 3 0
O166 HND (1) Spain 1 0
O167 (4) ND (2), H9 (1), H11 (1) Spain 3 0
O177 H11 (1) Spain 1 0
O178 H7 (1) Spain 1 0
O179 H31 (1) Spain 1 0
O115, O152 (15) HND (13), H8 (1), H10 (1) Spain 10 0
R (2) H11, 21 (1), H28 (1) Brazil 1 0
Table 4. Characterization of the espT-positive strains
Serotype
(no.
of strains)
Origin Pathotype espM Intimin Tir Tccp2 GenBank
accession no.
Group 1
O111:H9 (1) Finland aEPEC + f2 a1 +
ONT:H- (1) Brazil aEPEC + e2 a1 + FM992854
O49:H- (1) Brazil aEPEC + f2 a1 + FM992855
O85:H- (1) Brazil aEPEC – i1 a1 + FM992856
O109:H9 (1) Brazil aEPEC + e2 a1 + FM992857
O111:H- (1) Spain tEPEC + f2 a1 + FM992858
O123:H- (2) Brazil aEPEC + e2 a1 + FM992859
O154:H9 (1) Brazil aEPEC + f2 a1 + FM992860
Group 2
O2:H49 (1) Spain aEPEC – h1 h1 + FM992862
O2:H49 (1) Spain aEPEC – i1 a1 – FM992861
Group 3
ONT:H7 (1) Brazil aEPEC + b1 b1 – FM992863
O104:H2 (1) Spain aEPEC – b1 b1 + FM992864
O104:H2 (1) Brazil aEPEC – b1 b1 + FM992865
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In contrast espM was found in only 17 of 89 (19%) strains
belonging to the other non-O157 serogroups (Table 1).
All the O157 and non-O157 strains were espT gene
negative.
In order to confirm the absence of espM and espT from the
PCR gene-negative strains, we screened 50 O157 and non-
O157 EHEC strains with a second set of conserved espM
primers (espM-3 and espM-4) and three sets of espT
primers (espT-3 and espT-4, espT-5 and espT-6, and
espT-7 and espT-8). All the isolates remained espM and
espT gene negative in these tests.
Screening tEPEC and aEPEC isolates for the
presence of espM and espT
We screened a total of 132 tEPEC strains, isolated in Brazil,
Bolivia, Burundi, Spain, Chile, Germany, the UK and
Uruguay, and 602 aEPEC strains, isolated in Brazil, Bolivia,
Chile and Spain, for the presence of espM and espT. espM
was found in 91 tEPEC isolates (69%) belonging to 16
different serogroups (the O serogroup of 6 strains was non-
typable – ONT) (Table 2). espM was found in 258 aEPEC
isolates (43%) belonging to 59 different serogroups [the O
serogroup of 109 strains was ONT and of 2 isolates was O
rough (R)] (Table 3). Of the 109 ONT aEPEC, espM was
found in 45 isolates (41%). Among the aEPEC that shared
a serogroup with the major EHEC strains, espM was found
in 23 of 31 (74%) O26, 4 of 12 (33%) O103, 2 of 4 (50%)
O111, 25 of 33 (76%) O145 and 4 of 7 (57%) O157
isolates; in total 58 of 87 (67%). Interestingly, espM was
found in 94% (15 of 16) of the O55 strains, regardless of
serotype. espT was found in only 1 (0.8%) tEPEC strain
(O111:H-) isolated in Spain and in 12 aEPEC strains (2%)
(Table 3).
In order to confirm the absence of espM and espT from
the PCR gene-negative EPEC strains, we screened 50
tEPEC and 100 aEPEC strains with espM primers 3 and 4,
and espT primers 3 and 4, 5 and 6, and 7 and 8. All the
isolates remained espM and espT gene negative in these
tests.
Further characterization of the espT-positive
strains
Considering that espT was found in only 13 of the total 932
isolates tested, we sequenced their amplicons, and char-
acterized their virulence genes implicated in colonization
(e.g. intimin type) and pedestal formation (e.g. Tir type and
TccP2) as described previously (Garmendia et al., 2005b);
strain E110019 was used as a reference strain. Sequencing of
espT revealed a high level of sequence conservation (Table
4). In the eight strains EspT was identical to that of E110019,
defined as group 1 EspT. In two strains we detected a single
aminoaciddifference(group2)andinthreeotherstrainswe
found 6 amino acids that differed from the EspT of E110019
(group 3) (Fig. 1). All the espT-positive strains encoded a Tir
that can undergo tyrosine phosphorylation and thus trigger
strong actin polymerization in vitro via the Nck-N-WASP
pathway (Kenny, 1999; Gruenheid et al., 2001). All the
strains but two encoded TccP2, which can also activate the
N-WASP actin-signalling pathway (Whale et al., 2007).
Eight of the espT-positive strains (as well as E110019) also
encoded EspM.
Intimin typing was performed by sequencing the variable
39 end of the eae gene from the 14 espT-positive strains
(including E110019) (Table 4) (Blanco et al., 2006b). This
revealed known intimin types in 10 strains: b1 (3 strains),
e2 (4 strains), h1 (1 strain) and i1 (2 strains). Importantly,
we identified a new intimin variant, f2, in 4 of the espT
gene-positive strains (Table 4). We determined the
complete nucleotide sequence of two of the new eae-f2
variant genes (accession numbers FM872419 and
FM872420 for E110019 and T2381-8, respectively). Using
CLUSTAL W software for optimal sequence alignment with
the known 27 eae alleles, we found 98, 92 and 91%
sequence identity with the eae-f1 (AJ271407), eae-a1
(M58154) and eae-a2 (AF530555) genes, respectively.
Conclusions
Our results show that espM is found in approximately 96%
of the strains belonging to the major EHEC serogroups:
O26, O103, O111, O118, O145 and O157, and in a
Fig. 1. Multiple sequence alignment of
representative EspT sequences. The con-
served motif WxxxE is boxed. When compared
with EspTE110019, 8 of the 13 EspT showed
100% sequence identity (ONT:H-, O49:H-,
O85:H-, O109:H9, O111:H-, O123:H-
(2), O154:H9) as represented by sequence
EspT 1. Two strains belonging to serotype
O2:H49 had 1 amino acid difference, indi-
cated by dark grey (sequence EspT 2), while
three strains O104:H2 (2), ONT:H (7)
differed in 6 amino acids, indicated by dark
grey and light grey (sequence EspT 3).
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EHEC strains (P,0.05). Similarly, espM was also more
commonly found in EPEC serogroups O26, O55, O145 and
O157 than in other aEPEC. Among the tEPEC strains espM
was detected in approximately 69% of the tested isolates.
These results suggest that espM is more commonly found
in EPEC and EHEC serogroups that are linked to severe
human infections. In contrast, espT was found only
infrequently and only among EPEC strains (1 tEPEC and
12 aEPEC isolates). espT was first found in C. rodentium
and later in silico in EPEC E110019, which is of particular
interest as it was responsible for a particularly severe
diarrhoeal outbreak in Finland in 1987 that affected 650
individuals, including adults, in a school complex and an
additional 137 associated household members (Viljanen
et al., 1990). Comparing the protein sequences of EspT to
that of E110019 showed a high level of conservation, with
only three strains encoding EspT that differed in 6 amino
acids from the EspT of E110019. At present, it is not clear
why espT is so rare and what impact EspM and EspT have
on EPEC and EHEC infection.
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